" class="no-js "lang="en-US"> Hero Archives - Medtech Alert
Wednesday, June 12, 2024

Sort by:


Top Post

Protagen Protein Services Merges with GeneWerk to Integrate Leading Protein and Gene Therapy Analytic Platforms

Protagen Protein Services (PPS) today announced that it will merge with GeneWerk, an Ampersand portfolio […]

Largest Robotic Surgery Programme in UK to Tackle COVID Backlog

Guy’s and St Thomas‘ has taken delivery of a new surgical robot to help speed […]

AWS Announces AWS Healthcare Accelerator for Startups in the Public Sector

The healthcare industry is currently experiencing seismic shifts with much of the focus being placed […]

COVID-19 Welcomes a New Era in Vaccinology. mRNA Based Vaccines to Reach US$127.3 Billion by the Year 2027

A new market study published by Global Industry Analysts Inc., (GIA) the premier market research […]

Ixaka and SomaLogic Enter Research Collaboration to Develop Bispecific Agents for Oncology

Ixaka Ltd and SomaLogic today announce a research collaboration to support the development of aptamer-based […]

Q'Apel Medical raises $22 Million to grow innovative Neurovascular access platform & Scott Huennekens joins Board of Directors

Q’Apel Medical, Inc., an innovative neurovascular company specializing in developing and commercializing novel access device […]

Zocdoc raises $150 million

New York-based digital healthcare marketplace Zocdoc announced $150 million in growth financing from Francisco Partners, a […]

FDA approves new treatment for adults with relapsed or refractory large-b-cell lymphoma

Today, the U.S. Food and Drug Administration approved Breyanzi (lisocabtagene maraleucel), a cell-based gene therapy […]

Honeywell expands life sciences and software capabilities through acquisition of Sparta Systems

Honeywell today announced it has agreed to acquire privately held Sparta Systems for $1.3 billion in […]

  1. Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
  2. Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
  3. DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
  4. Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
  5. Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more